Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market

BACKGROUND: The price of antiretroviral drugs (ARVs) in low income countries declined steadily in recent years. This raises concerns about the commercial viability of the market of ARVs in low income countries. METHODS: Using 2 costing scenarios, we modeled the production cost of the most commonly u...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakakeeto, Olive N, Elliott, Brian V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577495/
https://www.ncbi.nlm.nih.gov/pubmed/23410145
http://dx.doi.org/10.1186/1744-8603-9-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577495/
https://www.ncbi.nlm.nih.gov/pubmed/23410145
http://dx.doi.org/10.1186/1744-8603-9-6

Ejemplares similares